BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Compounds That Target CD300LB

CD300LB · 16 compounds in BiohacksAI corpus

CD300LB (CD300LB) is a biological target with 16 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into CD300LB modulation for therapeutic and biohacking applications.

Most Studied Compounds for CD300LB
500+
studies
500+
studies
All 16 Compounds — Ranked by Evidence
1
Aconitum Carmichaelii
0.50
confidence
2
Allium Fistulosum
0.50
confidence
3
Apis Mellifera
0.50
confidence
4
Arctium Lappa
0.50
confidence
5
Bufo Bufo
0.50
confidence
6
Dendrobium Nobile
0.50
confidence
7
Euryale Ferox
0.50
confidence
8
Morus Alba
0.50
confidence
500+
studies
0.50
confidence
10
Prunus Armeniaca
0.50
confidence
11
Quisqualis Indica
0.50
confidence
12
Scrophularia Ningpoensis
0.50
confidence
13
Taraxacum Mongolicum
0.50
confidence
14
Tussilago Farfara
0.50
confidence
15
Vigna Radiata
0.50
confidence
500+
studies
0.50
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CD300LB (CD300LB). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CD300LB target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.